selected scholarly activity
-
academic article
- Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 41:439-455. 2023
- Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed-methods pilot study. BMJ Evidence-Based Medicine. bmjebm-2022-112098. 2023
- Canada population norms for the EQ-5D-5L. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 2023
- Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties. Value in Health. 26:251-260. 2023
- Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis. Canadian Journal of Anaesthesia. 69:1515-1526. 2022
- China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 40:957-969. 2022
- Cost-Effectiveness of Polygenic Risk Scores to Guide Statin Therapy for Cardiovascular Disease Prevention. Circulation: Genomic and Precision Medicine. 15:e003423. 2022
- How Do Health Schemas Inform Healthy Behaviours During Pregnancy? Qualitative Findings from the Be Healthy in Pregnancy (BHIP) Study. Maternal and Child Health Journal. 26:1861-1870. 2022
- Indirectness (transferability) is critical when considering existing economic evaluations for GRADE clinical practice guidelines: a systematic review. Journal of Clinical Epidemiology. 148:81-92. 2022
- A Systematic Literature Review of Health Utility Values in Breast Cancer. Medical Decision Making. 42:704-719. 2022
- Industry sponsorship bias in cost effectiveness analysis: registry based analysis. British Medical Journal BMJ (Clinical research ed.). 377:e069573-e069573. 2022
- Time-Specific Differences in Stated Preferences for Health in the United States. Medical Care. 60:462-469. 2022
- Responsiveness of the HUG-5 in an outpatient clinic: a 12-month randomised feasibility study protocol. BMJ Open. 12:e061057-e061057. 2022
- Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD). BMJ Open. 12:e053246-e053246. 2022
- Fighting COVID-19: a qualitative study into the lives of intensive care unit survivors in Wuhan, China. BMJ Open. 12:e055365-e055365. 2022
- Be Healthy in Pregnancy (BHIP): A Randomized Controlled Trial of Nutrition and Exercise Intervention from Early Pregnancy to Achieve Recommended Gestational Weight Gain. Nutrients. 14:810-810. 2022
- Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6:785-792. 2022
- Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents. Journal of Clinical Epidemiology. 142:133-143. 2022
- What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks. Value in Health. 25:302-317. 2022
- A look back at the first wave of COVID-19 in China: A systematic review and meta-analysis of mortality and health care resource use among severe or critical patients. PLoS ONE. 17:e0265117-e0265117. 2022
- More work needed on decision analysis for shared decision-making: A scoping review. Journal of Clinical Epidemiology. 141:106-120. 2022
- A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. Journal of Clinical Epidemiology. 140:69-78. 2021
- An international mixed methods study to develop a new preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMC Women's Health. 21:8. 2021
- Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care. Current Controlled Trials in Cardiovascular Medicine Trials. 22:531. 2021
- Temporal Trends and Factors Associated With the Inclusion of Patient‐Reported Outcomes in Heart Failure Randomized Controlled Trials: A Systematic Review. Journal of the American Heart Association. 10:e022353. 2021
-
Effect of patient‐centered transitional care services on patient‐reported outcomes in heart failure: sex‐specific analysis of the
PACT‐HF randomized controlled trial. European Journal of Heart Failure. 23:1488-1498. 2021 - Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT). PharmacoEconomics PharmacoEconomics - Italian Research Articles. 39:1075-1084. 2021
- Patient‐Reported Outcomes and Patient‐Reported Experience of Patients With Atrial Fibrillation in the IMPACT‐AF Clinical Trial. Journal of the American Heart Association. 10:e019783. 2021
- Guidelines that use the GRADE approach often fail to provide complete economic information for recommendations: A systematic survey. Journal of Clinical Epidemiology. 136:203-215. 2021
- Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease. Medical Decision Making. 41:685-692. 2021
- Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 22:723-733. 2021
- Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review*. Critical Care Medicine. 49:575-588. 2021
- Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 11:e046021-e046021. 2021
- Economic Analysis of Mobile Integrated Health Care Delivered by Emergency Medical Services Paramedic Teams. Jama Network Open. 4:e210055-e210055. 2021
- Be Healthy in Pregnancy: Exploring factors that impact pregnant women's nutrition and exercise behaviours. Maternal and Child Nutrition. 17:e13068. 2021
- Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China. Patient Preference and Adherence. Volume 15:775-783. 2021
- GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making. Journal of Clinical Epidemiology. 129:138-150. 2021
- A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trial. Current Controlled Trials in Cardiovascular Medicine Trials. 21:771. 2020
- Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial. Pilot and Feasibility Studies. 6:61. 2020
- 3125 steps to perfect health: a nonparametric approach to developing the EQ-5D-5L value set. Quality of Life Research. 29:3109-3118. 2020
- Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant. Plastic and Reconstructive Surgery - Global Open. 8:e3179-e3179. 2020
- Cost-effectiveness Analysis of Abdominal-based Autogenous Tissue and Tissue-expander Implant following Mastectomy. Plastic and Reconstructive Surgery - Global Open. 8:e2986-e2986. 2020
- Identifying factors associated with high use of acute care in Canada: protocol of a population-based retrospective cohort study. BMJ Open. 10:e038008-e038008. 2020
- Association of Roux-en-Y Gastric Bypass With Postoperative Health Care Use and Expenditures in Canada. JAMA Surgery. 155:e201985-e201985. 2020
- Economic evaluation of robot-assisted radical prostatectomy compared to open radical prostatectomy for prostate cancer treatment in Ontario, Canada. Journal of the Canadian Urological Association. 14:E350-E357. 2020
- Quantifying the impacts of human mobility restriction on the spread of COVID-19: an empirical analysis from 344 cities of China 2020
- Acceptability and Validity of the EQ-5D in Patients Living With Dementia. Value in Health. 23:760-767. 2020
- Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol. BMJ Open. 10:e036047-e036047. 2020
- Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool. American Heart Journal. 224:35-46. 2020
- The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound. Journal of Thoracic and Cardiovascular Surgery. 159:2499-2507.e3. 2020
- An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta. Healthcare Policy. 15:90-101. 2020
- Estimated Stroke-Free Survival of Folic Acid Therapy for Hypertensive Adults. Hypertension. 75:339-346. 2020
- Probiotics in hospitalized adult patients: a systematic review of economic evaluations. Canadian Journal of Anaesthesia. 67:247-261. 2020
- Stakeholders’ feedback on the proposed recommendations for updating the patented medicine prices review board (pmprb) budget impact analysis guidelines. Journal of Population Therapeutics and Clinical Pharmacology. 27:e1-e24. 2020
- International phase 1 study protocol to develop a health state classification system for a preference-based measure for women with breast cancer: the BREAST-Q Utility module. BMJ Open. 10:e034451-e034451. 2020
- A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. PharmacoEconomics - Open. 3:437-451. 2019
- Experiences regarding nutrition and exercise among women during early postpartum: a qualitative grounded theory study. BMC Pregnancy and Childbirth. 19:368. 2019
- Disease-specific Preference-based Measure of Glaucoma Health States. Journal of Glaucoma. 28:593-600. 2019
- Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer. MDM Policy and Practice. 4:238146831985259-238146831985259. 2019
- Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB). Medical Decision Making. 39:371-379. 2019
- Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer. Oncologist. 24:349-357. 2019
- Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma. Cancer Treatment Reviews. 74:43-48. 2019
- Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure. JAMA - Journal of the American Medical Association. 321:753-753. 2019
- Patient Experiences and Opinions of a Behavioral Activation Group Intervention for Depression. Research on Social Work Practice. 29:10-18. 2019
- Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology. JAMA Internal Medicine. 178:1586-1586. 2018
- FIT for FUNCTION: study protocol for a randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 19:39. 2018
- Item reduction and validation of the Chinese version of diabetes quality-of-life measure (DQOL). Health and Quality of Life Outcomes. 16:78. 2018
- Structured diet and exercise guidance in pregnancy to improve health in women and their offspring: study protocol for the Be Healthy in Pregnancy (BHIP) randomized controlled trial. Current Controlled Trials in Cardiovascular Medicine Trials. 19:691. 2018
- Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China. Diabetes/Metabolism Research and Reviews. 34:e3053-e3053. 2018
- Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand. PharmacoEconomics - Open. 2:297-308. 2018
- Out-of-Pocket Expenditures, Indirect Costs and Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Thailand. PharmacoEconomics - Open. 2:281-296. 2018
- Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 36:883-888. 2018
- Multimedia Appendix Correction: A Computer-Assisted Personal Interview App in Research Electronic Data Capture for Administering Time Trade-off Surveys (REDCap): Development and Pretest. JMIR Formative Research. 2:e11436-e11436. 2018
- Optimizing primary care management of atrial fibrillation: The rationale and methods of the Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) study. American Heart Journal. 201:149-157. 2018
- Preference-based Glaucoma-specific Health-related Quality of Life Instrument: Development of the Health Utility for Glaucoma. Journal of Glaucoma. 27:585-591. 2018
- Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial. American Heart Journal. 199:75-82. 2018
- Robotic Versus Video-Assisted Thoracoscopic Lung Resection During Early Program Development. Annals of Thoracic Surgery. 105:1050-1057. 2018
- Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada. PharmacoEconomics - Open. 2:19-29. 2018
- A Computer-Assisted Personal Interview App in Research Electronic Data Capture for Administering Time Trade-off Surveys (REDCap): Development and Pretest. JMIR Formative Research. 2:e3-e3. 2018
- A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions. ClinicoEconomics and Outcomes Research. Volume 10:821-854. 2018
- Conducting EQ-5D Valuation Studies in Resource-Constrained Countries: The Potential Use of Shrinkage Estimators to Reduce Sample Size. Medical Decision Making. 38:26-33. 2018
- GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences—inconsistency, imprecision, and other domains. Journal of Clinical Epidemiology. 111:83-93. 2018
- Feasibility of an altruistic sperm donation program in Canada: results from a population-based model. Reproductive Health. 14:8. 2017
- Transforming Latent Utilities to Health Utilities: East Does Not Meet West. Health Economics. 26:1524-1533. 2017
- Pulmonary Rehabilitation With Balance Training for Fall Reduction in Chronic Obstructive Pulmonary Disease: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 6:e228-e228. 2017
- Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 18:967-977. 2017
- A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors. Human Vaccines. 13:1765-1767. 2017
- Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Quality of Life Research. 26:2057-2066. 2017
- Health literacy and logical inconsistencies in valuations of hypothetical health states: results from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 26:1483-1492. 2017
- Forty-two systematic reviews generated 23 items for assessing the risk of bias in values and preferences' studies. Journal of Clinical Epidemiology. 85:21-31. 2017
- Erratum to: The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status. Obesity Surgery. 27:1128-1128. 2017
- Handling Regional Variation in Health State Preferences within a Country. Medical Decision Making. 37:252-261. 2017
- Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value in Health. 20:644-650. 2017
- Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value in Health. 20:644-650. 2017
- Underestimation of Variance of Predicted Health Utilities Derived from Multiattribute Utility Instruments. Medical Decision Making. 37:262-272. 2017
- Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma. JAMA Oncology. 3:366-366. 2017
- Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape. Immunotherapy. 9:375-378. 2017
- Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers. Clinical Chemistry. 63:593-602. 2017
- The Effect of Bariatric Surgery on Mobility, Health-Related Quality of Life, Healthcare Resource Utilization, and Employment Status. Obesity Surgery. 27:349-356. 2017
- Behavioral activation group therapy for reducing depressive symptoms and improving quality of life: a feasibility study. Pilot and Feasibility Studies. 2:22. 2016
- Can the general public use vignettes to discriminate between Alzheimer’s disease health states?. BMC Geriatrics. 16:36. 2016
- EQ-5D-derived health utilities and minimally important differences for chronic health conditions: 2011 Commonwealth Fund Survey of Sicker Adults in Canada. Quality of Life Research. 25:3009-3016. 2016
- Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 34:1087-1100. 2016
- Preference-based disease-specific health-related quality of life instrument for glaucoma: a mixed methods study protocol. BMJ Open. 6:e012732-e012732. 2016
- Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol. BMJ Open. 6:e012909-e012909. 2016
- How different are composite and traditional TTO valuations of severe EQ-5D-5L states?. Quality of Life Research. 25:2101-2108. 2016
- Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 25:1679-1685. 2016
- Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Quality of Life Research. 25:979-986. 2016
- Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility. Medical Decision Making. 36:223-233. 2016
- A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada. Medical Care. 54:98-105. 2016
- Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study. PLoS ONE. 11:e0162422-e0162422. 2016
- How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations. Quality of Life Research. 25:35-43. 2016
- A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol. Pilot and Feasibility Studies. 1:39. 2015
- Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 16:847-855. 2015
- Patient-reported health preferences of anticoagulant-related outcomes. Journal of Thrombosis and Thrombolysis. 40:268-273. 2015
- A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE). PharmacoEconomics PharmacoEconomics - Italian Research Articles. 33:867-877. 2015
- Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 33:2296-2302. 2015
- The economics of adalimumab for ulcerative colitis. Expert Review of Pharmacoeconomics and Outcomes Research. 15:373-377. 2015
- Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation. Cardiovascular Drugs and Therapy. 28:575-585. 2014
- Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China. Value in Health. 17:A782-A782. 2014
- Impact of Demographics on Health Preferences in China: An Exploratory Analysis of China EQ-5D-5L Valuation Study. Value in Health. 17:A753-A753. 2014
- Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values. Medical Care. 52:935-943. 2014
- Assessment of Preference for Hormonal Treatment–Related Health States among Patients with Breast Cancer. Value in Health Regional Issues. 3:27-32. 2014
- Eliciting preferences to the EQ-5D-5L health states: discrete choice experiment or multiprofile case of best–worst scaling?. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 15:281-288. 2014
- Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study. Hospital practice (1995). 42:38-45. 2014
- Comparing EQ-5D Valuation Studies. Medical Decision Making. 34:8-20. 2014
- A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine. 5:205ra134. 2013
- A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Journal of the Canadian Urological Association. 7:335-335. 2013
- Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective. Journal of Thoracic and Cardiovascular Surgery. 146:52-60.e3. 2013
- Model-based economic evaluation for medical decision making: learn from the past and prepare for the future.. Journal of Thoracic Disease. 5:209-210. 2013
- Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 31:501-508. 2013
- Cost-Effectiveness of Pharmaceutical Management for Osteoarthritis Pain. Drugs and Aging. 30:277-284. 2013
- Scoring the 5-Level EQ-5D. Medical Decision Making. 33:567-578. 2013
- Conceptual Framework for Health-related Quality of Life Assessment in Acute Gastroenteritis. Journal of Pediatric Gastroenterology and Nutrition. 56:280-289. 2013
- Cost Effectiveness of Treatment Options for Early Prostate Cancer: Can We Put the Puzzle Pieces Together?. European Urology. 63:411-412. 2013
- Reply to the Editor. Journal of Thoracic and Cardiovascular Surgery. 145:608-609. 2013
- Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation. International Journal of Vascular Medicine. 2013:1-11. 2013
- Photoselective vaporization for the treatment of benign prostatic hyperplasia.. Ontario Health Technology Assessment Series. 13:1-34. 2013
- The excess burden of rheumatoid arthritis in Ontario, Canada.. Clinical and Experimental Rheumatology. 31:18-24. 2013
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update.. Ontario Health Technology Assessment Series. 13:1-40. 2013
- Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis. Journal of Interventional Cardiac Electrophysiology Cardiac Electrophysiology Review. 35:259-275. 2012
- Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review. Genetic Testing Genetic Testing and Molecular Biomarkers. 16:1322-1335. 2012
- Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada. Value in Health. 15:894-906. 2012
- Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore. Value in Health Regional Issues. 1:46-53. 2012
- Health State Utility Assessment for Breast Cancer. Value in Health Regional Issues. 1:93-97. 2012
- Measuring health-related quality-of-life for Alzheimer’s disease using the general public. Quality of Life Research. 21:593-601. 2012
- Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study. Hospital practice (1995). 40:131-137. 2012
- The excess burden of osteoarthritis in the province of Ontario, Canada. Arthritis and Rheumatism. 64:1153-1161. 2012
- Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 138:455-462. 2012
- Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease. Journal of Crohn's and Colitis. 6:77-85. 2012
- An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore. Value in Health. 15:S72-S78. 2012
- Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.. Journal of Population Therapeutics and Clinical Pharmacology. 19:e166-e178. 2012
- Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. ClinicoEconomics and Outcomes Research. 4:287-287. 2012
- Discussing study limitations in reports of biomedical studies-the need for more transparency. Health and Quality of Life Outcomes. 10:23-23. 2012
- Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. ClinicoEconomics and Outcomes Research. 4:21-21. 2012
- Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based Analysis (part B).. Ontario Health Technology Assessment Series. 12:1-62. 2012
- The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskeletal Disorders. 12:209. 2011
- Calculating Utility Decrements Associated With an Adverse Event. Medical Decision Making. 31:790-799. 2011
- Calculating Utility Decrements Associated With an Adverse Event: Marginal Tobit and CLAD Coefficients Should Be Used With Caution. Medical Decision Making. 31:790-799. 2011
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis. Seminars in Arthritis and Rheumatism. 41:178-186. 2011
- Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Review of Pharmacoeconomics and Outcomes Research. 11:513-521. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources.. International Journal of Circumpolar Health. 70:417-427. 2011
- Estimation of the impact of diabetes-related complications on health utilities for patients with type 2 diabetes in Ontario, Canada. Quality of Life Research. 20:939-943. 2011
- Ontario Multidetector Computed Tomographic Coronary Angiography Study. Archives of Internal Medicine A.M.A. archives of internal medicine Archives of internal medicine (Chicago, Ill. : 1908). 171:1021-1029. 2011
- Triple Therapy for the Management of COPD: A Review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 8:206-243. 2011
- Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis. International Journal of Rheumatic Diseases. 14:206-210. 2011
- Health economic evaluations help inform payers of the best use of scarce health care resources. International Journal of Circumpolar Health. 70:419-427. 2011
- Should Endovascular Repair Be Reimbursed for Low Risk Abdominal Aortic Aneurysm Patients? Evidence from Ontario, Canada. International Journal of Vascular Medicine. 2011:1-10. 2011
- Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. ClinicoEconomics and Outcomes Research. 3:89-89. 2011
- Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health and Quality of Life Outcomes. 8:116. 2010
- Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index. Value in Health. 13:873-878. 2010
- General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals. Expert Review of Pharmacoeconomics and Outcomes Research. 10:379-384. 2010
- Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?. Value in Health. 13:487-494. 2010
- Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario. Value in Health. 13:S8-S11. 2010
- A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment. PharmacoEconomics PharmacoEconomics - Italian Research Articles. 28:255-277. 2010
- Patient outcomes after anti TNF-α drugs for Crohn’s disease. Expert Review of Pharmacoeconomics and Outcomes Research. 10:163-175. 2010
- Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. European Journal of Health Economics HEPAC Health Economics in Prevention and Care. 11:27-34. 2010
- Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.. Open Medicine. 4:e154-e166. 2010
- A review of health utilities across conditions common in paediatric and adult populations. Health and Quality of Life Outcomes. 8:12-12. 2010
- Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Effectiveness and Resource Allocation. 8:14-14. 2010
- Evaluation of health outcomes in osteoarthritis patients after total knee replacement: a two-year follow-up. Health and Quality of Life Outcomes. 8:87-87. 2010
- Approaches for Economic Evaluations of Health Care Technologies. Journal of the American College of Radiology. 6:307-316. 2009
- Conditionally Funded Field Evaluations and Practical Trial Design Within a Health Technology Assessment Framework. Journal of the American College of Radiology. 6:324-331. 2009
- Health Technology Assessment and Primary Data Collection for Reducing Uncertainty in Decision Making. Journal of the American College of Radiology. 6:332-342. 2009
- Illustrating Economic Evaluation of Diagnostic Technologies: Comparing Helicobacter pylori Screening Strategies in Prevention of Gastric Cancer in Canada. Journal of the American College of Radiology. 6:317-323. 2009
- Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in canadian adults with chronic immune thrombocytopenic purpura. Clinical Therapeutics. 31:1082-1091. 2009
- In search of the evidentiary foundation of published Canadian economic evaluations (2001–06). International Journal of Technology Assessment in Health Care. 25:214-221. 2009
- A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada. Value in Health. 12:245-252. 2009
- Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder. International Journal of Psychiatry in Clinical Practice. 13:59-69. 2009
- Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis. Cost Effectiveness and Resource Allocation. 7:20-20. 2009
- Excess Risk of Mortality and Complications Associated with Newly Diagnosed Cases of Diabetes in Ontario, Canada. Canadian Journal of Diabetes. 33:93-104. 2009
- Prevalence, Total and Excess Costs of Diabetes and Related Complications in Ontario, Canada. Canadian Journal of Diabetes. 33:35-45. 2009
- Economic evaluations conducted by Canadian health technology assessment agencies: Where do we stand?. International Journal of Technology Assessment in Health Care. 24:437-444. 2008
- The need for standardization: A literature review of indirect costs of rheumatoid arthritis and osteoarthritis. Arthritis and Rheumatism. 59:1027-1033. 2008
- Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Quality of Life Research. 17:595-601. 2008
- A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore. Value in Health. 11:S84-S90. 2008
- Applying the Expectancy-Value Model to Understand Health Values. Value in Health. 11:S61-S68. 2008
- Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore. Value in Health. 11:S3-S10. 2008
- Psychometric evaluation of the Schizophrenia Quality of Life Scale (SQLS) in English- and Chinese-speaking Asians in Singapore. Quality of Life Research. 17:115-122. 2008
- Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model. World Journal of Gastroenterology. 14:3021-3021. 2008
- Cost-effectiveness analysis of Helicobacter pylori screening in prevention of gastric cancer in Chinese. International Journal of Technology Assessment in Health Care. 24:87-95. 2008
- Validation of the International Classification of Functioning, Disability, and Health (ICF) Brief Core Set for osteoarthritis. Scandinavian Journal of Rheumatology. 37:450-461. 2008
- Validation of the Comprehensive ICF Core Set for Osteoarthritis (OA) in patients with knee OA: a Singaporean perspective.. Journal of Rheumatology. 34:2301-2307. 2007
- Are Asians comfortable with discussing death in health valuation studies? A study in multi-ethnic Singapore. Health and Quality of Life Outcomes. 4:93. 2006
- Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore. Human Psychopharmacology. 20:459-465. 2005
- The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore. Quality of Life Research. 14:1181-1186. 2005
-
conference paper
- United States Valuation of EQ-5D-5L Health States: An Initial Model Using a Standardized Protocol. Value in Health. S4-S5. 2018
- ROBOTIC-ASSISTED THORACOSCOPIC PULMONARY RESECTION VERSUS VIDEO-ASSISTED THORACOSCOPIC PULMONARY RESECTION FOR EARLY STAGE NON-SMALL CELL LUNG CANCER: A HEALTHCARE UTILIZATION ANALYSIS. Value in Health. A105-A105. 2017
- Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Quality of Life Research. 132-132. 2016
- Health literacy and logical inconsistencies in valuations of hypothetical health states: data from the Canadian EQ-5D-5L valuation study. Quality of Life Research. 24-25. 2016
- A time trade-off-derived value set of the 5-level EQ-5D for Canada. Quality of Life Research. 53-54. 2015
- Determinants of health preferences in the Canadian EQ-5D-5L Valuation Study. Quality of Life Research. 177-178. 2015
- Instrument-defined estimates of minimally important difference in EQ-5D-5L index score for Canadian, Chinese and Spanish scoring algorithms. Quality of Life Research. 181-181. 2015
- EQ-5D health utilities are estimated subject to considerable uncertainty. Value in Health. A195-A195. 2014
- The Canadian Eq-5d Valuation Study: Estimating Time Trade-Off Values For The Eq-5d-5l. Value in Health. A163-A163. 2014
- Use Of Economic Evidence To Inform Drug Reimbursement Decision Making: The Case For Ontario. Value in Health. A18-A18. 2014
- Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D. Value in Health. A326-A326. 2013
- The EQ-5D-5L international protocol and the Canadian experience. Quality of Life Research. 2013
- Are canadians different from americans in stated preferences for health? valuing EQ-5D-5L health states using discrete choice experiments. Value in Health. A32-A32. 2013
- COMPARING EQ-5D VALUATION STUDIES: A SYSTEMATIC REVIEW AND METHODOLOGICAL REPORTING CHECKLIST. Value in Health. A45-A45. 2013
- HEALTH UTILITIES INDEX (R) : EXTENDING THE AGE RANGE TO PRE-SCHOOLERS. Value in Health. A36-A36. 2013
- Valuing EQ-5D-5L: Can latent utilities derived from a discrete choice model be transformed to health utilities derived from time trade-off tasks?. Value in Health. A31-A31. 2013
- CHARACTERISTICS OF THE ABORIGINAL PEOPLE WITH DIABETES IN THE SOUTH-WESTERN OF ONTARIO, CANADA. Value in Health. A495-A496. 2012
- PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada. Value in Health. A499-A499. 2012
- PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada. Value in Health. A507-A507. 2012
- PRM6 Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis. Value in Health. A646-A646. 2012
- Evidence from four countries on the validity of the discrete choice model in quantifying health-states for the new EQ-5D-5L. Quality of Life Research. 12-12. 2012
- PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling. Value in Health. A198-A199. 2012
- PCN127 Health State Utility Assessment for Breast Cancer. Value in Health. A457-A457. 2011
- PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies. Value in Health. A260-A260. 2011
- PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS. Value in Health. A119-A120. 2011
- PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS. Value in Health. A83-A83. 2011
- PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS. Value in Health. A150-A151. 2011
- HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO. Value in Health. A133-A133. 2010
- PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHN'S DISEASE. Value in Health. A73-A73. 2010
- PMS74 USE OF A DISEASE-SPECIFIC INSTRUMENT IN ECONOMIC EVALUATIONS: MAPPING WOMAC ONTO THE EQ-5D UTILITY INDEX. Value in Health. A136-A136. 2010
- PRS7 TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Value in Health. A197-A197. 2010
- UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO. Value in Health. A133-A134. 2010
- DB1 USING POPULATION-BASED ESTIMATES FOR DISEASE MODELING: POTENTIAL BIAS COMPARED TO USING DISEASE-SPECIFIC DEATH AND COMPLICATION RISK ESTIMATES. Value in Health. A234-A234. 2009
- PDB21 WHO ARE THEY FOOLING?: COST OF DISEASE OR COMPLICATIONS CAN SIGNIFICANTLY BIAS ESTIMATES UNLESS CONTROL (NON-DISEASED) COSTS ARE NOT ALSO ACCOUNTED FOR IN THE ANALYSIS. Value in Health. A405-A405. 2009
- PG14 SYSTEMATIC REVIEW: THE CLINICAL EFFECTIVENESS OF ANTI-TNFALPHA DRUGS IN ADULTS WITH REFRACTORY CROHN'S DISEASE. Value in Health. A346-A346. 2009
- PHP80 CLINICAL EFFECTIVENESS OF PORTABLE ULTRASOUND IN SMALL EMERGENCY DEPARTMENTS: A SYSTEMATIC REVIEW. Value in Health. A252-A252. 2009
- PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP. Value in Health. A374-A374. 2009
- PSY18 THE BURDEN OF OBESITY IN ONTARIO. Value in Health. A378-A378. 2009
- PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA. Value in Health. A380-A381. 2009
- PGI6 COST EFFECTIVENESS ANALYSIS OF ANTI-TNF-ALPHA; DRUGS FOR REFRACTORY ULCERATIVE COLITIS. Value in Health. A58-A58. 2009
- PMS45 EXTENSION FROM INPATIENTS TO OUTPATIENTS: PERFORMANCE OF THE OXFORD KNEE SCORE IN MEASURING HEALTH OUTCOMES IN PATIENTS WITH KNEE OSTEOARTHRITIS. Value in Health. A72-A72. 2009
- PSY9 USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF OBESITY IN ADULTS LIVING IN ONTARIO. Value in Health. A131-A131. 2009
- QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA. Value in Health. A17-A17. 2009
- PGI7 COST EFFECTIVENESS ANALYSIS OF HELICOBACTER PYLORI SCREENING IN PREVENTION OF GASTRIC CANCER IN CHINESE. Value in Health. A85-A86. 2008
- PMS34 ATWO-YEAR EVALUATION OF HEALTH OUTCOMES IN OSTEOARTHRITIS PATIENTS AFTERTOTAL KNEE REPLACEMENT. Value in Health. A265-A265. 2008
- PAR32 INVESTIGATION OF RESPONSE SHIFT IN HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS UNDERGOINGTOTAL KNEE REPLACEMENT. Value in Health. A253-A253. 2007
- PND27 DETECTION OF DIFFERENTIAL ITEM FUNCTIONING BETWEEN ENGLISH AND CHINESE VERSIONS OF THE PDQ-8. Value in Health. A94-A95. 2007
- PAR11 ARE THEY MEASURABLE? A STUDY ON ELICITING INDIRECT AND INTANGIBLE COSTS OF KNEE OSTEOARTHRITIS USING HUMAN CAPITAL APPROACH AND WILLINGNESS-TO-PAY IN MULTIETHNIC ASIAN POPULATION IN SINGAPORE. Value in Health. A223-A223. 2006
- PMC13 APPLYING EXPECTANCY-VALUE MODEL TO UNDERSTAND HEALTH PREFERENCE-AN EXPLORATORY STUDY. Value in Health. A59-A60. 2006
- Optimizing caching policy for loss recovery in reliable multicast. Proceedings - IEEE INFOCOM. 568-579. 2006
- PAR10 ARE THEY RELEVANT? A CRITICAL EVALUATION OF THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH CORE SETS FOR OSTEOARTHRITIS FROM THE PERSPECTIVE OF PATIENTS WITH KNEE OSTEOARTHRITIS IN SINGAPORE. Value in Health. A27-A27. 2005
- PCN22 THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE CORE QUESTIONNAIRE (EORTC QLQ-C30): VALIDATION OF ENGLISH VERSION IN SINGAPORE. Value in Health. 252-252. 2004